arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Iovance Biotherapeutics, Inc.

IOVA Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$4.23
▼ -3.4% Today
as of Jun 7, 07:18 ET
Last 30 days +25.15% Apr 28 → Jun 05
$3.22 $3.53 $3.85 $4.16 $4.47 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$4.50
High
$4.56
Low
$4.17
Volume
$20M
Avg Vol
$15M
Mkt Cap
$1.9B
P/E (TTM)
Beta
52w High
$5.63
52w Low
$1.66
Div Yield
Shares Out
$438M

Overview

52-week range
$1.66
$5.63
65% of range
Avg surprise (last 2)
-22.0%
Avg reaction (last 2)
-6.0%
50% positive
Latest IV / EM
76%
EM ±7.1% · $4 · Jun 12

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.47$-0.40$-0.33$-0.26$-0.19 Actual $-0.47Actual $-0.46Actual $-0.42Actual $-0.34Actual $-0.28Actual $-0.36Est $-0.25Actual $-0.33Actual $-0.19Est $-0.19 JunSepMarJunSepMar/2025JunMar/2026
Revenue vs Net Income Revenue Net income
$-116M$-108M$-100M$-91M$-83M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.19 $-0.19 0.0% +47.2% -13.2% earnings
Mon Jun 30, 2025Jun 2025 $-0.33 financials
Thu May 8, 2025Mar/2025 $-0.36 $-0.25 -44.0% +1.3% earnings
Mon Sep 30, 2024Sep 2024 $-0.28 financials
Sun Jun 30, 2024Jun 2024 $-0.34 financials
Sun Mar 31, 2024Mar 2024 $-0.42 financials
Sat Sep 30, 2023Sep 2023 $-0.46 financials
Fri Jun 30, 2023Jun 2023 $-0.47 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$42M$38M$57M$43M$32M$31M
Gross profit
Operating income$-81M$-95M$-114M$-121M$-89M$-102M
Net income$-79M$-91M$-112M$-116M$-84M$-97M
EPS (diluted)$-0.19$-0.33$-0.36$-0.28$-0.34

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$197M$163M$158M$132M$172M$116M$164M$229M
Inventory$58M$52M$52M$50M$66M$52M$39M$28M
Total current assets$467M$443M$429M$422M$513M$457M$499M$482M
Total assets$926M$913M$905M$907M$967M$910M$991M$964M
Long-term debt
Total liabilities$204M$215M$203M$209M$199M$200M$218M$196M
Total equity$722M$699M$702M$698M$768M$710M$773M$769M

Implied volatility — last 90 days

70%73%75%78%80% Jun 07 — IV 76% · EM ±7.1%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.